GMV 0.00% 3.9¢ g medical innovations holdings limited

GMV Chart, page-2181

  1. 6,165 Posts.
    lightbulb Created with Sketch. 2345
    Thanks @adamho
    Yacov is unlikely to sell undet 51%.
    He will earn ~80% of 2x60M perf shares & some of 26m options.
    In short Yacov controls 51-58% when fully diluted (~510m sh/op) assuming both targets/milestones are reached in may19 & may20.

    With Yacov+mgt+Top300 holding
    90-95% of 510M sh/op, some 20-25M shares may be floating around.

    @richk_banker
    Short answer:
    By jan-mar2020
    Gmv holds
    51% Gyim (U$1 Bn MCap)
    =U$510m

    +
    100% USA/GMedDx, pre IPO
    (U$1 Bn MCap, minimum for Nasdaq)
    =U$1000m

    =U$1510m
    =A$2000m , 510m sh/op
    =A$3.50 to $4.00

    Aimo. GltLTHs.
    (For longer answers pls read the threads.
    A2M? Xero?. Cochlear?)
    .
    Last edited by Glyco: 28/09/18
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.